14 November 2018 2 Min Read
Regulator halts trading of Samsung BioLogics’ shares
Korea's Financial Services Commission says company's listing under review for breaching accounting rules
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In